Zogenix
is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases... Read moreZogenix
is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases... Read more
News
Mar 28, 2022
PharmaLive
Zogenix: FDA Greenlights UCB Drug for Severe Form of Epilepsy
Mar 08, 2022
Pharamceutical Technology
Zogenix: UCB concludes acquisition of biopharma firm Zogenix for $1.9bn
Mar 07, 2022
Citybizlist
Zogenix: UCB Acquires Zogenix
Mar 07, 2022
MarketScreener
Zogenix: Zogenix : Amendment to Annual Report (Form 10-K/A)
Mar 04, 2022
FirstWord Pharma
Zogenix: Zogenix To Present New Long-term Data on FINTEPLA (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022
Mar 04, 2022
MarketScreener
Zogenix: UCB : Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of Zogenix, Inc.
Feb 28, 2022
FirstWord Pharma
Zogenix: UCB Announces Extension of Tender Offer to Acquire Zogenix, Inc.
Feb 28, 2022
Associated Press News
Zogenix: Zogenix: Q4 Earnings Snapshot
Feb 28, 2022
MarketScreener
Zogenix: Zogenix : Provides Corporate Update and Reports Fourth Quarterand Full-Year 2021 Financial Results - Form 8-K
Feb 15, 2022
Genomeweb
Zogenix: Zogenix, UMDF, Probably Genetic Sponsor Free Mitochondrial Disease Genetic Testing Program
Zogenix Competitors
1
2
3
4
5
6
7
8